A Case of Mycobacterium gordonae Pulmonary Disease in a Patient with Ulcerative Colitis Treated with Infliximab / 대한내과학회지
Korean Journal of Medicine
; : 452-456, 2015.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-153843
Biblioteca responsável:
WPRO
ABSTRACT
Tumor necrosis factor-alpha (TNF-alpha) is a key component of the host defense against mycobacterial infection. Mycobacterium gordonae (M. gordonae) is one of the least virulent mycobacteria, and is generally considered non-pathogenic if detected from a clinical specimen. Here, we report a rare case of pulmonary M. gordonae infection in a patient with ulcerative colitis who had been treated with infliximab, a TNF-alpha antagonist. M. gordonae infection was treated successfully with clarithromycin, rifampin, and ethambutol. We believe this to be the first report of M. gordonae pulmonary disease associated with TNF-alpha antagonist treatment.
Texto completo:
Disponível
Contexto em Saúde:
Doenças Negligenciadas
Problema de saúde:
Tuberculose
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Rifampina
/
Úlcera
/
Colite Ulcerativa
/
Fator de Necrose Tumoral alfa
/
Claritromicina
/
Bactéria Gordonia
/
Etambutol
/
Infliximab
/
Pneumopatias
/
Mycobacterium
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Ano de publicação:
2015
Tipo de documento:
Artigo